Negative side effects can lead to patient non-adherence, but offering the right supplements at the right time can help get patients back on track.

As the COVID-19 vaccine rollout continues, Amplicare is introducing two new features to help pharmacies ensure patients are fully vaccinated.

Having the option of a plan with no DIR fees creates a win-win situation where both the patient and the pharmacy benefit from a plan change.

Two new features are improving the pharmacist experience with the Dual Eligible Report in Amplicare Match.

Changing the pharmacy reimbursement model would reduce DIR fees, encourage pharmacists to provide clinical services, and lower barriers for patient care.

Medicare plan formularies change yearly. With a formulary lookup tool, pharmacists can help patients understand what these changes mean for their coverage.

By prioritizing plan comparisons for dual eligible patients, pharmacies can act on opportunities to improve care and lower DIR fees all year.

Are your patients becoming eligible for Medicare? From the types of Medicare to enrollment options, here’s what they should know.

With more than 12 million Medicare beneficiaries dually eligible for Medicare and Medicaid, prioritizing these patients year round could be beneficial to the pharmacy.

If increasing your pharmacy’s profitability is a key goal this year, here are four areas to focus on this quarter.